Structural Modeling and in Silico Screening of Potential
Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor
Posted on 2019-01-11 - 09:14
The
glucagon-like peptide 1 receptor (GLP-1R) belongs to the pharmaceutically
important class B family of G-protein-coupled receptors (GPCRs), and
its incretin peptide ligand GLP-1 analogs are adopted drugs for the
treatment of type 2 diabetes. Despite remarkable antidiabetic effects,
GLP-1 peptide-based drugs are limited by the need of injection. On
the other hand, developing nonpeptidic small-molecule drugs targeting
GLP-1R remains elusive. Here, we first constructed a three-dimensional
structure model of the transmembrane (TM) domain of human GLP-1R using
homology modeling and conformational sampling techniques. Next, a
potential allosteric binding site on the TM domain was predicted computationally.
In silico screening of druglike compounds against this predicted allosteric
site has identified nine compounds as potential GLP-1R agonists. The
independent agonistic activity of two compounds was subsequently confirmed
using a cAMP response element-based luciferase reporting system. One
compound was also shown to stimulate insulin secretion through in
vitro assay. In addition, this compound synergized with GLP-1 to activate
human GLP-1R. These results demonstrated that allosteric regulation
potentially exists in GLP-1R and can be exploited for developing small-molecule
agonists. The success of this work will help pave the way for small-molecule
drug discovery targeting other class B GPCRs through allosteric regulations.
CITE THIS COLLECTION
DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
Redij, Tejashree; Chaudhari, Rajan; Li, Zhiyu; Hua, Xianxin; Li, Zhijun (2019). Structural Modeling and in Silico Screening of Potential
Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor. ACS Publications. Collection. https://doi.org/10.1021/acsomega.8b03052
or
Select your citation style and then place your mouse over the citation text to select it.
SHARE
Usage metrics
Read the peer-reviewed publication
AUTHORS (5)
TR
Tejashree Redij
RC
Rajan Chaudhari
ZL
Zhiyu Li
XH
Xianxin Hua
ZL
Zhijun Li
KEYWORDS
class B GPCRsPotential Small-Molecule Allosteric AgonistscompoundGLP -1R agonistssmall-molecule drug discoveryclass B familyincretin peptide ligand GLPtype 2 diabetesglucagon-like peptide 1 receptorGlucagon-like Peptide 1 ReceptorcAMP response element-based luciferaseTMnonpeptidic small-molecule drugsGLP -1Rallosteric binding site